Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1961 1
1962 5
1963 3
1964 4
1965 4
1966 9
1967 4
1968 5
1969 10
1970 13
1971 15
1972 17
1973 6
1974 6
1975 6
1976 9
1977 4
1978 2
1979 2
1980 3
1981 1
1983 4
1985 1
1986 1
1987 3
1988 2
1989 3
1990 3
1991 4
1992 4
1993 2
1994 2
1995 2
1996 2
1997 1
1998 2
1999 1
2000 4
2001 3
2002 3
2003 1
2004 7
2005 9
2006 12
2007 9
2008 4
2009 7
2010 8
2011 9
2012 8
2013 5
2014 9
2015 9
2016 10
2017 8
2018 11
2019 10
2020 13
2021 11
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

317 results
Results by year
Filters applied: . Clear all
Page 1
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq.
Song Q, Hawkins GA, Wudel L, Chou PC, Forbes E, Pullikuth AK, Liu L, Jin G, Craddock L, Topaloglu U, Kucera G, O'Neill S, Levine EA, Sun P, Watabe K, Lu Y, Alexander-Miller MA, Pasche B, Miller LD, Zhang W. Song Q, et al. Among authors: miller ld. Cancer Med. 2019 Jun;8(6):3072-3085. doi: 10.1002/cam4.2113. Epub 2019 Apr 29. Cancer Med. 2019. PMID: 31033233 Free PMC article.
Iron addiction: a novel therapeutic target in ovarian cancer.
Basuli D, Tesfay L, Deng Z, Paul B, Yamamoto Y, Ning G, Xian W, McKeon F, Lynch M, Crum CP, Hegde P, Brewer M, Wang X, Miller LD, Dyment N, Torti FM, Torti SV. Basuli D, et al. Among authors: miller ld. Oncogene. 2017 Jul 20;36(29):4089-4099. doi: 10.1038/onc.2017.11. Epub 2017 Mar 20. Oncogene. 2017. PMID: 28319068 Free PMC article.
Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study.
Forsythe SD, Erali RA, Sasikumar S, Laney P, Shelkey E, D'Agostino R Jr, Miller LD, Shen P, Levine EA, Soker S, Votanopoulos KI. Forsythe SD, et al. Among authors: miller ld. Clin Cancer Res. 2021 Sep 15;27(18):5141-5150. doi: 10.1158/1078-0432.CCR-21-0982. Epub 2021 Jul 1. Clin Cancer Res. 2021. PMID: 34210684 Free PMC article.
Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
Liu Y, Wang L, Song Q, Ali M, Crowe WN, Kucera GL, Hawkins GA, Soker S, Thomas KW, Miller LD, Lu Y, Bellinger CR, Zhang W, Habib AA, Petty WJ, Zhao D. Liu Y, et al. Among authors: miller ld. Nat Nanotechnol. 2022 Feb;17(2):206-216. doi: 10.1038/s41565-021-01032-w. Epub 2021 Dec 16. Nat Nanotechnol. 2022. PMID: 34916656 Free PMC article.
Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy.
Su J, Song Q, Qasem S, O'Neill S, Lee J, Furdui CM, Pasche B, Metheny-Barlow L, Masters AH, Lo HW, Xing F, Watabe K, Miller LD, Tatter SB, Laxton AW, Whitlow CT, Chan MD, Soike MH, Ruiz J. Su J, et al. Among authors: miller ld. Front Oncol. 2021 Apr 6;10:615472. doi: 10.3389/fonc.2020.615472. eCollection 2020. Front Oncol. 2021. PMID: 33889540 Free PMC article.
APOL1 Kidney-Risk Variants Induce Mitochondrial Fission.
Ma L, Ainsworth HC, Snipes JA, Murea M, Choi YA, Langefeld CD, Parks JS, Bharadwaj MS, Chou JW, Hemal AK, Petrovic S, Craddock AL, Cheng D, Hawkins GA, Miller LD, Hicks PJ, Saleem MA, Divers J, Molina AJA, Freedman BI. Ma L, et al. Among authors: miller ld. Kidney Int Rep. 2020 Mar 30;5(6):891-904. doi: 10.1016/j.ekir.2020.03.020. eCollection 2020 Jun. Kidney Int Rep. 2020. PMID: 32518871 Free PMC article.
SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysis.
Liu L, Ahmed T, Petty WJ, Grant S, Ruiz J, Lycan TW, Topaloglu U, Chou PC, Miller LD, Hawkins GA, Alexander-Miller MA, O'Neill SS, Powell BL, D'Agostino RB Jr, Munden RF, Pasche B, Zhang W. Liu L, et al. Among authors: miller ld. Mol Oncol. 2021 Feb;15(2):462-472. doi: 10.1002/1878-0261.12831. Epub 2020 Dec 17. Mol Oncol. 2021. PMID: 33107184 Free PMC article.
317 results